Suchergebnisse - (Person:"Wang, Xinning")

PubPharm (7)

1

GCP III is not the "off-target" for urea-based PSMA ligands

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Lee, Z. | Heston, W. | Wang, X. | +1

CommentOn: Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):957-961. - PMID 36184692

2

A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer

enthalten in: Theranostics | 2022

von Wang, X. | Sun, R. | Wang, J. | +8

3

The transcription factor STAT5 catalyzes Mannich ligation reactions yielding inhibitors of leukemic cell proliferation

enthalten in: Nature communications | 2019

von Wong, E. | Nawrotzky, E. | Arkona, C. | +7

4

Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen

enthalten in: Molecular cancer therapeutics | 2016

von Wang, X. | Tsui, B. | Ramamurthy, G. | +6

5

Structure-activity relationships of 2',5'-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists

enthalten in: Nucleosides, nucleotides & nucleic acids | 2012

von Wang, X. | Tian, H. | Lee, Z. | +1

6

Targeted treatment of prostate cancer

enthalten in: Journal of cellular biochemistry | 2007

von Wang, X. | Yin, L. | Rao, P. | +4

7

2-5A ligands--a new concept for the treatment of prostate cancer

enthalten in: Nucleosides, nucleotides & nucleic acids | 2007

von Cramer, H. | Okicki, J. | Rho, T. | +3

1
[1]